We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 9426) during anaesthesia with nitrous oxide, fentanyl and isoflurane after a single bolus dose of rocuronium 0.6 mg kg-1 in nine patients with chronic renal failure requiring regular haemodialysis, and in nine healthy control patients. Blood samples were collected over 390 min and concentrations of rocuronium and its putative metabolites measured using HPLC. Onset time for maximum block, duration of clinical relaxation (T1(25)) and recovery index, were 61 (SD 25.0) s and 65 (16.4) s, 55 (26.9) min and 42 (9.3) min and 28 (12.3) min and 19 (8.8) min, respectively, for patients with and without renal failure. The time for TOF ratio to return spont...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
BACKGROUND AND AIM: The neuromuscular effects of a bolus dose of rocuronium 0.6 mg kg(-1) under prop...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
Background: This study aimed to investigate the neuromuscular effects of 0.6 mg/kg rocuronium under...
BACKGROUND AND OBJECTIVE: This study clarifies the relationship between the neuromuscular blocking e...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
BACKGROUND AND AIM: The neuromuscular effects of a bolus dose of rocuronium 0.6 mg kg(-1) under prop...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We have studied the onset and duration of action and pharmacokinetics of rocuronium bromide (Org 942...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaest...
Background: This study aimed to investigate the neuromuscular effects of 0.6 mg/kg rocuronium under...
BACKGROUND AND OBJECTIVE: This study clarifies the relationship between the neuromuscular blocking e...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
We have studied the pharmacokinetics of a single bolus of rocuronium (Org 9426), followed by an infu...
BACKGROUND AND AIM: The neuromuscular effects of a bolus dose of rocuronium 0.6 mg kg(-1) under prop...
Study Objective: To evaluate the time course of action, dose requirement, reversibility, and pharmac...